178 related articles for article (PubMed ID: 34966670)
1. Splicing Factor DDX23, Transcriptionally Activated by E2F1, Promotes Ovarian Cancer Progression by Regulating FOXM1.
Zhao C; Li Y; Qiu C; Chen J; Wu H; Wang Q; Ma X; Song K; Kong B
Front Oncol; 2021; 11():749144. PubMed ID: 34966670
[TBL] [Abstract][Full Text] [Related]
2. METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation.
Lin C; Li T; Wang Y; Lai S; Huang Y; Guo Z; Zhang X; Weng S
Cell Death Dis; 2023 Mar; 14(3):221. PubMed ID: 36977668
[TBL] [Abstract][Full Text] [Related]
3. DEAD-box RNA helicase DDX23 modulates glioma malignancy via elevating miR-21 biogenesis.
Yin J; Park G; Lee JE; Choi EY; Park JY; Kim TH; Park N; Jin X; Jung JE; Shin D; Hong JH; Kim H; Yoo H; Lee SH; Kim YJ; Park JB; Kim JH
Brain; 2015 Sep; 138(Pt 9):2553-70. PubMed ID: 26121981
[TBL] [Abstract][Full Text] [Related]
4. Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression.
Barger CJ; Zhang W; Hillman J; Stablewski AB; Higgins MJ; Vanderhyden BC; Odunsi K; Karpf AR
Oncotarget; 2015 Sep; 6(29):27613-27. PubMed ID: 26243836
[TBL] [Abstract][Full Text] [Related]
5. The DEAD-box RNA helicase DDX5 (p68) and β-catenin: The crucial regulators of FOXM1 gene expression in arbitrating colorectal cancer.
Tabassum S; Basu M; Ghosh MK
Biochim Biophys Acta Gene Regul Mech; 2023 Jun; 1866(2):194933. PubMed ID: 36997114
[TBL] [Abstract][Full Text] [Related]
6. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
[TBL] [Abstract][Full Text] [Related]
7. The DDX23 Negatively Regulates Translation and Replication of Foot-and-Mouth Disease Virus and Is Degraded by 3C Proteinase.
Abdullah SW; Han S; Wu J; Zhang Y; Bai M; Jin Y; Zhi X; Guan J; Sun S; Guo H
Viruses; 2020 Nov; 12(12):. PubMed ID: 33255534
[TBL] [Abstract][Full Text] [Related]
8. MnSOD promotes tumor invasion via upregulation of FoxM1-MMP2 axis and related with poor survival and relapse in lung adenocarcinomas.
Chen PM; Wu TC; Shieh SH; Wu YH; Li MC; Sheu GT; Cheng YW; Chen CY; Lee H
Mol Cancer Res; 2013 Mar; 11(3):261-71. PubMed ID: 23271813
[TBL] [Abstract][Full Text] [Related]
9. FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator system.
Huang C; Xie D; Cui J; Li Q; Gao Y; Xie K
Clin Cancer Res; 2014 Mar; 20(6):1477-88. PubMed ID: 24452790
[TBL] [Abstract][Full Text] [Related]
10. A patient-derived organoid-based study identified an ASO targeting SNORD14E for endometrial cancer through reducing aberrant FOXM1 Expression and β-catenin nuclear accumulation.
Chen X; Liu X; Li QH; Lu BF; Xie BM; Ji YM; Zhao Y
J Exp Clin Cancer Res; 2023 Sep; 42(1):230. PubMed ID: 37667311
[TBL] [Abstract][Full Text] [Related]
11. Fork head box M1 regulates vascular endothelial growth factor-A expression to promote the angiogenesis and tumor cell growth of gallbladder cancer.
Wang RT; Miao RC; Zhang X; Yang GH; Mu YP; Zhang ZY; Qu K; Liu C
World J Gastroenterol; 2021 Feb; 27(8):692-707. PubMed ID: 33716448
[TBL] [Abstract][Full Text] [Related]
12. FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression.
Hu G; Yan Z; Zhang C; Cheng M; Yan Y; Wang Y; Deng L; Lu Q; Luo S
J Exp Clin Cancer Res; 2019 May; 38(1):188. PubMed ID: 31072351
[TBL] [Abstract][Full Text] [Related]
13. FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer.
Hamurcu Z; Kahraman N; Ashour A; Ozpolat B
Breast Cancer Res Treat; 2017 Jun; 163(3):485-493. PubMed ID: 28361350
[TBL] [Abstract][Full Text] [Related]
14. FOXM1c promotes oesophageal cancer metastasis by transcriptionally regulating IRF1 expression.
Zhou Y; Wang Q; Chu L; Dai W; Zhang X; Chen J; Zhang L; Ding P; Zhang X; Gu H; Zhang P; Li L; Zhang W; Li L; Lv X; Zhou D; Cai G; Chen L; Zhao K; Hu W
Cell Prolif; 2019 Mar; 52(2):e12553. PubMed ID: 30485581
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer.
Wen N; Wang Y; Wen L; Zhao SH; Ai ZH; Wang Y; Wu B; Lu HX; Yang H; Liu WC; Li Y
J Transl Med; 2014 May; 12():134. PubMed ID: 24885308
[TBL] [Abstract][Full Text] [Related]
16. DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling.
Chan DW; Hui WW; Wang JJ; Yung MM; Hui LM; Qin Y; Liang RR; Leung TH; Xu D; Chan KK; Yao KM; Tsang BK; Ngan HY
Oncogene; 2017 Mar; 36(10):1404-1416. PubMed ID: 27593933
[TBL] [Abstract][Full Text] [Related]
17. Aberrant activation of ERK/FOXM1 signaling cascade triggers the cell migration/invasion in ovarian cancer cells.
Lok GT; Chan DW; Liu VW; Hui WW; Leung TH; Yao KM; Ngan HY
PLoS One; 2011; 6(8):e23790. PubMed ID: 21858223
[TBL] [Abstract][Full Text] [Related]
18. MFAP2 aggravates tumor progression through activating FOXM1/β-catenin-mediated glycolysis in ovarian cancer.
Zhao LQ; Sun W; Zhang P; Gao W; Fang CY; Zheng AW
Kaohsiung J Med Sci; 2022 Aug; 38(8):772-780. PubMed ID: 35546486
[TBL] [Abstract][Full Text] [Related]
19. A Positive Feedback Loop of lncRNA-
Xu MD; Wang Y; Weng W; Wei P; Qi P; Zhang Q; Tan C; Ni SJ; Dong L; Yang Y; Lin W; Xu Q; Huang D; Huang Z; Ma Y; Zhang W; Sheng W; Du X
Clin Cancer Res; 2017 Apr; 23(8):2071-2080. PubMed ID: 27756785
[No Abstract] [Full Text] [Related]
20. DDX23, an Evolutionary Conserved dsRNA Sensor, Participates in Innate Antiviral Responses by Pairing With TRIF or MAVS.
Ruan J; Cao Y; Ling T; Li P; Wu S; Peng D; Wang Y; Jia X; Chen S; Xu A; Yuan S
Front Immunol; 2019; 10():2202. PubMed ID: 31620127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
